How big is the Body Contouring Devices Market?

The Body Contouring Devices Market size is expected to reach USD 1.40 billion in 2024 and grow at a CAGR of 14% to reach USD 3.35 billion by 2029. Read More

What is the current Body Contouring Devices Market size?

In 2024, the Body Contouring Devices Market size is expected to reach USD 1.40 billion. Read More

Who are the key players in Body Contouring Devices Market?

Hologic Inc. (Cynosure), Bausch Health Companies Inc, Boston Scientific (Lumenis), AbbVie (Allergen) and Candela Corporation are the major companies operating in the Body Contouring Devices Market. Read More

Which is the fastest growing region in Body Contouring Devices Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Body Contouring Devices Market?

In 2024, the North America accounts for the largest market share in Body Contouring Devices Market. Read More

What years does this Body Contouring Devices Market cover, and what was the market size in 2023?

In 2023, the Body Contouring Devices Market size was estimated at USD 1.20 billion. The report covers the Body Contouring Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Body Contouring Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Body Contouring Devices Market Share

Statistics for the 2023 & 2024 Body Contouring Devices market share, created by Mordor Intelligence™ Industry Reports. Body Contouring Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Body Contouring Devices Industry

The body contouring devices market is moderately concentrated in nature due to the presence of companies operating globally and regionally. The competitive landscape includes analyzing companies, including Hologic Inc., Candela Corporation, Bausch Health Companies Inc., Allergan Plc, and Leumenis, among others.